360 likes | 758 Views
Brig Mazhar Ishaq Advisor in Ophthalmology, Comdt Armed Forces Institute Of Ophthalmology, Rwp. RED EYE- UVEITIS. ANATOMICAL CLASSIFICATION. ANTERIOR UVEITIS IRITIS IRIDOCYCLITIS INTERMEDIATE UVEITIS POSTERIOR UVEITIS PANUVEITIS. POSTERIOR UVEITIS.
E N D
Brig Mazhar Ishaq Advisor in Ophthalmology, Comdt Armed Forces Institute Of Ophthalmology, Rwp RED EYE- UVEITIS
ANATOMICAL CLASSIFICATION • ANTERIOR UVEITIS • IRITIS • IRIDOCYCLITIS • INTERMEDIATEUVEITIS • POSTERIOR UVEITIS • PANUVEITIS
POSTERIOR UVEITIS Involves the fundus posterior to the vitreous base - Retinitis - Choroiditis - Vasculitis
SARCOIDOSIS • Presentation - Acute - Insidious • Ocular features - AAU - CAU - Intermediate - Candlewax drippings’ - Multifocal choroiditis - Retinal granulomas
TUBERCULOSIS Anterior segment involvement Tuberculousuveitis - Anterior uveitis, - Choroiditis - Periphlebitis
TOXOPLASMOSIS • Presentation - Unilateral sudden onset of floaters • Signs - Spill-over’ anterior uveitis- Satellite lesion- Multiple foci are uncommon - Severe vitritis (‘headlight in the fog’)
BEHCET SYNDROME • Recurrent oro-genital ulceration • Ocular features • AAU - cold abscess • Retinitis • Retinal vasculitis • Vitritis,
INVESTIGATIONS Indications • Recurrent granulomatous anterior uveitis • Bilateral disease • Systemic manifestations with out a specific diagnosis • Confirmation of suspective ocular picture such as HLA-A29 testing in birdshortchorioretinopathy
NOT NECESSARY • Single attack of mild unilateral acute anterior uveitis • A specific uveitis entity • When a systemic diagnosis compatible with the uveitis is already apparent
INVESTIGATIONS • Obtain a history, attempting to define the etiology. • Complete ocular examination, including an IOP check and a dilated fundus examination.
SKIN TESTS • Tuberculin skin test (montoux & Heaf) • Intradermal inj of purified protein • Positive Induration of 5-14 mm with in 48 hours Negative • Excludes TB • May occure in advanced disease
PATHERGY TEST • Increased dermal sensitivity to needle trauma • Behcet syndrome • Rarely positive in absence of systemic activity • Pustule formation
SEROLOGY SYPHILIS • Non-treponemal tests RPR or VDRL • Primary infection • Monitor disease activity • Response to therapy
Immunofluorescent antibody test • Haemagglutination test
Enzyme-linked Immunosorbent Assay (ELISA) • Antibodies in aqueous (more specific) • Other conditions (cat-scratch fever & toxocariasis Antinuclear Antibody (ANA) • In children with JIA who are at high risk of developing ant uveitis
ENZYME ASSAY • Angiotensin converting enzyme (ACE) • Nonspecific test • Granulomatous disease like - Sarcoidosis (elevated in 80% & in acute) - TB - Leprosy • Lysozyme • Good sensitivity but less speceficity for sarcoidosis
HLA TISSUE TYPING HLA type Associated disease B27 Spondyloarthropathies A29 Birdshot chorioretinopathy B51 Behcet syndrome HLA-B7 & POHS & APMPPE HLA-DR2
IMAGING • Fluorescein angiography (FA) • Retinal vasculitis • CMO • Indocyanine angiography (ICG) • Better for choroidal disease
Ultrasonography (US) • It is useful in opaque media especially in excluding a RD or intraocular mass • Optical coherence tomography(OCT) • Detecting CMO • Identify vitreoretinal traction as a mechanism of CMO
BIOPSY Histopathology still remains the gold-standard • conjunctiva And Lacrimal gland - Sarcoidosis • Aqueous samples - For (polymerase chain reaction) PCR - Viral retinitis (occasionally) • Vitreous biopsy - Infectious endophthalmitis
RADIOLOGY • Chest X-rays - To exclude TB and Sarcoidosis • Sacro-illiac joint X-Rays - Diagnosis of spondyloarthropathy • CT & MRI - Sarcoidosis - Multiple sclerosis - Primary intraocular lymphoma
TREATMENT • AIM • Prevent vision threatening complications • Relieve patients discomfort • Treat the underlying cause • FOUR GROUP OF DRUGS • Mydriatics • Steroids • Cyclosporine • Cytotoxic agents
TREATMENT • Mydriatics • To give comfort • To prevent formation of posterior synechia • To break down synechia • Drugs (atropine, homatropine, scopolamine, tropicamide)
TREATMENT • Steroids (mainstay of treatment) • Topical administration • Complications (glaucoma, posterior sub capsular cataract, corneal complications, systemic side effects) • Periocular injections • Severe acute anterior uveitis • Adjuvant to topical/systemic • Poor compliance • Pre op
TREATMENT • Systemic therapy • Preparations • Prednisolone 5mg • Indications • Rules • Start with large dose then reduce • Initial dose 1-1.5 mg/kg BW • Before breakfast • Taper off • Less than 2 weeks abrupt stop
TREATMENT • Side effects • Short term • Long term
TREATMENT • Cyclosporin • Steroid sparing agent • Complications are hypertension and nephrotoxicity • Cytotoxic drugs • Potentially blinding bilateral reversible uveitis • Intolerable side effects from systemic steroids therapy.